In this study, we demonstrated that FOXO3a inhibited mammosphere formation ability, percentages of ALDH+ cells, subpopulation of CD44+/CD24− cells in vitro, and tumorigenicity in vivo, which supported an important role of FOXO3a in inhibiting CSC properties of breast cancer cells. Here, CD44 is linked to breast carcinoma.